Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. Abstract submission deadline for RSV2025 has been extended to 15 November.
13th International RSV Symposium (RSV2025)
   
   

 Return to Menu

 RSV2022 Exhibition

 RSV2022 Prospectus floor FinalV5   Copy
StandExhibitor
 1  EFCNI
 2  ESWI
 3  Sanofi Medical
 4  MSD
 5  QUIDEL
 6  hVivo
7+8  AstraZeneca
9+10 Janssen   

​​​​

 

Meet the Exhibitors



2018 EFCNI foundation text 

The European Foundation for the Care of Newborn Infants (EFCNI) is the first pan-European organisation
and network to represent the interests of preterm and newborn infants and their families. It brings together parents, healthcare experts from different disciplines, and scientists with the common goal of improving long-term health of preterm and newborn children. EFCNI’s vision is to ensure the best start in life for every baby.
For more information visit the website

 ESWI logo

The European Scientific Working group on Influenza (ESWI) is a network of independent influenza experts and organisations of public health officials, healthcare professionals, at-risk patients and the elderly. Together, we aim to reduce the burden of influenza in Europe.

Visit the website


 Logo JPG

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. 

Visit the website


 02852 MSD Logo Horizontal TealGrey RGB  
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than
a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
 
       Visit the website
 

 image009

Quidel is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. Visit the website


hvivo 2022 logo 2col w stripe   resized 

hVIVO is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and longstanding client base of biopharma companies.

Visit the website


AstraZeneca   High Res Logo

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Visit the website

Follow the Company on Twitter @AstraZeneca


 jsn logo prof vert color cmyk u 01

About the Janssen Pharmaceutical Companies of Johnson & Johnson -

At Janssen, we’re creating a future where disease is a thing of the past.

We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular; Metabolic & Retinal Diseases; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.

Visit the website

Janssen-Cilag Limited is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.